UBS has initiated coverage of Shaily Engineering Plastics with a ‘Buy’ rating and a target price of ₹4,000, indicating a 60% upside. The firm highlights Shaily’s patented technology and strong market position for GLP-1 therapies, estimating substantial revenue growth and a 75% EPS CAGR by FY28.
Source :- mint – markets Read More

